Ningbo Chinese Medicine is a national high-tech enterprise specializing in the research and development, production and sales of Chinese raw materials, Chinese herbal extracts, functional foods, and health products. It belongs to the life and health industry supported by the National 125 Plan. The company is a modern enterprise that strictly complies with the pharmaceutical GMP standards. After moving from Ningbo City to the new site in Beilun National Economic Development Zone in 2008, the first phase was completed and put into production in May 2010, and the second phase was completed and put into production in July 2014. The third phase will be launched annually and is expected to be completed and put into production in June. The company has production licenses for medicines, foods and food additives, and strictly operates and manages in accordance with ISO and HACCP standardized management systems. The company has a building area of ​​12,000 square meters, including a storage area of ​​3,500 square meters. The company can now process more than 8,000 tons of Chinese herbal medicines and other effective plant raw materials, and the third phase of production will increase to more than 15,000 tons. The high-quality and high-specification product series developed and produced by Ningbo Chinese Medicine are mainly based on traditional Chinese medicine extracts for both medicine and food, supplemented by natural herbal plant extracts widely recognized by developed countries in Europe and America. The research and development direction is committed to focusing on the development of anti-aging , Anti-cancer, anti-tumor, anti-oxidation, energy-enhancing, and natural plant-based active ingredients with health effects such as improving human immunity. After years of development, the company has a mature three-dimensional platform for R&D, production, processing, packaging, sales, storage and transportation, and can provide customers with a full range of integrated services. The company's products have been widely used in domestic and foreign industries such as pharmaceuticals, dietary supplements, food and beverages, food additives, feed and feed additives, and daily cosmetics. The product development thinking of Ningbo Chinese Medicine is based on the principle of small but precise, and strives to make one product into one, and strive to become a major and specialized product for each key development product. The current leading products of Ningbo Traditional Chinese Medicine include: curcumin and turmeric complete series, ginkgo biloba extract, huperzine A, puerarin and flavonoids, quinoa levodopa, mulberry anthocyanins, astragaloside IV and polysaccharides, green tea tea polyphenols And catechins, gypenosides, salidroside, myricetin and myricin, grape seed proanthocyanidins, bilberry anthocyanins, ginsenosides, ginseng saponins, notoginseng triol saponins, mulberry leaf 1-DNJ, mugwort leaves Lanxanthin, lycopene, oleuropein, olive hydroxytyrosol, Polygonum cuspidatum resveratrol and other pure natural plant monomer extracts. Ningbo Traditional Chinese Medicine adheres to the sales philosophy of coexisting domestic and international markets. The technology and output of curcumin products are currently in a leading position in the world. The company successfully completed the corporate shareholding system restructuring in April 2015 and completed its listing (833528.CO) in September of the same year. The company will usher in a new round of rapid development opportunities. I believe that in the not-too-distant future, Ningbo Chinese Medicine will shine brightly on the five continents!

Registered Capital:  21.295 million (yuan)

Registered Address:  No. 525 Yuanbaoshan Road, Daqi, Zhejiang Province

Company Type:  Production

Business Scope:  Licensed items: pharmaceutical production; pharmaceutical wholesale; food production; food business; food additive production; production of sanitary products and disposable medical products; import and export of goods; import and export agency; Business activities can only be carried out after the approval of the department, and the specific business projects are subject to the approval results). General items: purchase of primary agricultural products; production, sales, processing, transporta